Roslin Institute Revenue and Competitors
Estimated Revenue & Valuation
- Roslin Institute's estimated annual revenue is currently $22.8M per year.
- Roslin Institute's estimated revenue per employee is $112,200
Employee Data
- Roslin Institute has 203 Employees.
- Roslin Institute grew their employee count by 5% last year.
Roslin Institute's People
Name | Title | Email/Phone |
---|
Roslin Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.1M | 69 | -13% | $16.5M | N/A |
#2 | $264.2M | 1850 | -1% | N/A | N/A |
#3 | $51.9M | 401 | -10% | $12.6M | N/A |
#4 | $22.5M | 205 | -39% | $63.8M | N/A |
#5 | $1.1M | 21 | -19% | $781.7K | N/A |
#6 | $21.3M | 190 | 33% | N/A | N/A |
#7 | $11.9M | 117 | 10% | N/A | N/A |
#8 | $3.8M | 46 | -10% | N/A | N/A |
#9 | $8.8M | 86 | -16% | N/A | N/A |
#10 | $2.5M | 31 | -40% | N/A | N/A |
What Is Roslin Institute?
Learn about working at Roslin Institute. Join LinkedIn today for free. See who you know at Roslin Institute, leverage your professional network, and get hired.
keywords:N/AN/A
Total Funding
203
Number of Employees
$22.8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Roslin Institute News
2022-04-13 - Rejuvenation of woman's skin could tackle diseases of ageing
The origins of the technique stem from the 1990s, when researchers at the Roslin Institute just outside Edinburgh developed a method of...
2022-04-06 - Gene editing expert appointed director of the Roslin Institute
Developmental Biology at the Roslin Institute, a position he held for 12 years. Prior to that, he held research positions at the...
2022-03-22 - The people cloning their pets
The Roslin Institute scientists had been attempting to clone a sheep using a complex process called nuclear transfer.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $60.3M | 203 | N/A | N/A |
#2 | $22.3M | 203 | -1% | N/A |
#3 | $39.1M | 203 | 3% | N/A |
#4 | $15M | 203 | 9% | N/A |
#5 | $56M | 203 | 9% | N/A |